Sign in
4

Changes in Ownership

Prelude Therapeutics Inc Filed Acc 0001231919-26-000422

10% owner disposed of 1,407,000 shares (other)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
RA CAPITAL MANAGEMENT, L.P. 10% owner 2026-04-27 Other disposition −1,407,000 6,475,882 I: show line 1 in the form

Table II: Derivative

Insider Date Transaction Shares Price Value Exercise Expires Underlying Owned after D/I
RA CAPITAL MANAGEMENT, L.P. 10% owner 2026-04-27 Other acquisition · Pre-Funded Warrants (Right to Buy) +1,407,000 1,407,000 I: show line 2 in the form
Loading xslF345X06/form4-04282026_090449.xml…